Research & Development

A groundbreaking study offers a novel strategy in the relentless fight against neurodegeneration by borrowing one of modern oncology's most powerful weapons and turning it against the pathologies of the brain. The research demonstrates, for the first time in a living animal model, that an

The quiet confidence that comes with taking a daily pill to manage cholesterol or blood pressure often masks a dangerous misconception that its protective shield is impenetrable, regardless of what one eats. This belief, however, is being challenged by rigorous scientific inquiry, forcing a

A profound shift in understanding the genetic roots of hypermobile Ehlers–Danlos syndrome is underway, as a landmark study dismantles the long-standing theory of a single-gene cause for this complex and often debilitating condition. For decades, the search for a solitary genetic culprit has left

With a deep background in biopharmaceutical research and development, Ivan Kairatov has a keen eye for innovations that could reshape how we treat the most challenging cancers. Today, he joins us to discuss a promising new preclinical study on pancreatic ductal adenocarcinoma (PDAC), a notoriously

Beyond the malignant cells of a brain tumor lies an equally destructive force, a relentless physical pressure that silently and systematically dismantles the delicate architecture of the mind long before the cancer itself infiltrates surrounding tissue. While medical science has long focused on

In the highly competitive world of biopharmaceuticals, where fortunes can shift with a single clinical trial update, Nektar Therapeutics has delivered a powerful reminder of the value of persistence and innovative science. The company's shares experienced a dramatic upward trajectory after it